Variability And Growth In Spending For Outpatient Specialty Pharmaceuticals
- 1 July 2005
- journal article
- research article
- Published by Health Affairs (Project Hope) in Health Affairs
- Vol. 24 (4) , 1117-1127
- https://doi.org/10.1377/hlthaff.24.4.1117
Abstract
Specialty pharmaceuticals are a unique group of drug agents used to treat complex clinical conditions. Many specialty pharmaceuticals are biological in nature and administered through injection or infusion. Tracking spending on these pharmaceuticals is complex, because these products may be processed as either medical or pharmacy claims. This benchmarking study of ten Blue Cross Blue Shield plans, representing almost eighteen million covered lives, documents large expenditures on select specialty pharmaceutical categories and much variation in spending across plans, age groups, and time. Our results underscore the need for insurers to scrutinize trends in specialty pharmaceutical spending and identify appropriate management strategies.Keywords
This publication has 2 references indexed in Scilit:
- Part1 How the Emergence of Innovative Biologic Agents Impacts Benefit Design, Utilization, and Provider RelationsJournal of Managed Care Pharmacy, 2004
- BibliographyBiotechnology Law Report, 2003